F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54698/133719_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | ![](/images/24961/54941_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/685/1469_B_1_5_rna_selected_60x60.jpg) | Group enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1901/6360_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
FHL2 | Four and a half LIM domains 2 | | | | | ![](/images/6028/18426_B_8_8_rna_selected_60x60.jpg) | Group enriched |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/30189/65080_B_9_8_rna_selected_60x60.jpg) | Tissue enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/11284/26941_A_1_6_rna_selected_60x60.jpg) | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/4417/19185_B_1_7_rna_selected_60x60.jpg) | Tissue enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/52887/143241_B_7_4_rna_selected_60x60.jpg) | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | ![](/images/4438/19508_B_9_3_rna_selected_60x60.jpg) | Group enriched |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/9247/32859_A_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | ![](/images/2267/7977_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | ![](/images/275/1253_A_2_2_rna_selected_60x60.jpg) | Group enriched |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins
| | ![](/images/6432/if_selected_60x60.jpg) | | ![](/images/6432/18314_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
KLHL41 | Kelch-like family member 41 | Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/21165/48902_A_1_8_rna_selected_60x60.jpg) | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/133/2841_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
KRT17 | Keratin 17 | Cancer-related genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/29/378_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
KRT5 | Keratin 5 | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/59479/133812_B_8_1_rna_selected_60x60.jpg) | Group enriched |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/31686/67663_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2301/if_selected_60x60.jpg) | | ![](/images/13967/30400_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | ![](/images/3494/if_selected_60x60.jpg) | | ![](/images/3816/10092_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Transcription factors
| | ![](/images/2087/if_selected_60x60.jpg) | | ![](/images/2087/7385_B_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | ![](/images/7891/22296_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2967/9462_A_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
MAGEC1 | Melanoma antigen family C, 1 | Cancer-related genes Plasma proteins
| | ![](/images/15452/if_selected_60x60.jpg) | | ![](/images/15452/34433_A_3_1_rna_selected_60x60.jpg) | Tissue enriched |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | ![](/images/22275/50911_A_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | ![](/images/1984/5294_A_2_8_rna_selected_60x60.jpg) | Tissue enriched |
MAP6 | Microtubule-associated protein 6 | | | ![](/images_static/na_center.gif) | | ![](/images/15442/34823_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/60/1942_B_9_4_rna_selected_60x60.jpg) | Group enriched |
MLANA | Melan-A | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/57/1379_B_6_4_rna_selected_60x60.jpg) | Tissue enriched |
MLPH | Melanophilin | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/14685/57496_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/13/117_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | ![](/images/395/142119_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21147/146570_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/8855/25361_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MUC5AC | Mucin 5AC, oligomeric mucus/gel-forming | Predicted secreted proteins
| | ![](/images/40456/if_selected_60x60.jpg) | | ![](/images/40615/124255_B_5_8_rna_selected_60x60.jpg) | Tissue enriched |
MYL4 | Myosin, light chain 4, alkali; atrial, embryonic | Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/51884/144152_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/142/2717_A_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes
| | ![](/images_static/na_center.gif) | | ![](/images/47836/129864_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | ![](/images/18587/40689_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | ![](/images/26111/58724_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | ![](/images/56798/136001_A_2_6_rna_selected_60x60.jpg) | Group enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | ![](/images/7308/19162_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | ![](/images/12047/28141_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | ![](/images/51038/137898_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | ![](/images/1081/if_selected_60x60.jpg) | | ![](/images/1081/2768_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | ![](/images/9257/141347_B_8_4_rna_selected_60x60.jpg) | Group enriched |
PLEK | Pleckstrin | Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/31838/68854_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |